NCT07334431
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, First-line Therapy, +11 more
- Locations
-
- Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University) Zhengzhou, Henan, China
Clinical trial condition
First-line Therapy
Explore clinical trials studying First-line Therapy. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
First-line Therapy trial results
Not Yet Recruiting
Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT07533305
- Conditions
- ESCC, First-line Therapy, QL1706
- Locations
-
Not specified
Not Yet Recruiting
Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer
NCT07129018
- Conditions
- Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +5 more
- Locations
-
Not specified
Not Yet Recruiting
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037
- Conditions
- First-line Therapy, Fruquintinib, GEJ Adenocarcinoma, +3 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
Completed
CAPOX + Bevacizumab + Tislelizumab Treating PD-L1 CPS < 5 Locally Advanced or Metastatic GEA
NCT05299476
- Conditions
- Advanced Gastroesophageal Adenocarcinoma, First-line Therapy, PDL1 CPS < 5
- Locations
-
- Chinese PLA General Hospital Beijing, China